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SUMMARY
FK506-binding protein 12 (FKBP12) binds the immu-
nosuppressant drugs FK506 and rapamycin and
regulates several signaling pathways, including
mammalian target of rapamycin (mTOR) signaling.
We determined whether the brain-specific disruption
of the FKBP12 gene in mice altered mTOR signaling,
synaptic plasticity, and memory. Biochemically, the
FKBP12-deficient mice displayed increases in basal
mTOR phosphorylation, mTOR-Raptor interactions,
and p70 S6 kinase (S6K) phosphorylation. Electro-
physiological experiments revealed that FKBP12
deficiency was associated with an enhancement in
long-lasting hippocampal long-term potentiation
(LTP). The LTP enhancement was resistant to rapa-
mycin, but not anisomycin, suggesting that altered
translation control is involved in the enhanced
synaptic plasticity. Behaviorally, FKBP12 conditional
knockout (cKO) mice displayed enhanced contextual
fear memory and autistic/obsessive-compulsive-like
perseveration in several assays including the water
maze, Y-maze reversal task, and the novel object rec-
ognition test. Our results indicate that FKBP12 plays
a critical role in the regulation of mTOR-Raptor inter-
actions, LTP, memory, and perseverative behaviors.
INTRODUCTION
FK506-binding proteins (FKBPs) originally were described as
ubiquitously expressed immunophillins that mediate the phar-
macological activities of naturally occurring macrolide immuno-
suppressants such as FK506 and rapamycin. It is now known
that FKBPs have a broader range of functions. FKBPs are
peptidyl-prolyl cis-trans isomerases (PPiases) involved in the
conversion of cis-proline residues to a less sterically restricted
trans conformation. FKBPs also are involved in the regulation
of intracellular calcium release, gene transcription, protein trans-
lation, and cellular trafficking (Harrar et al., 2001). FKBP12, the
smallest of member of the FKBP family, has a basic domain,
a PPiase catalytic domain, and a drug-binding pocket, all of
which are characteristic of the FKBP family.
FKBP12modulates the activity of several receptor complexes,
including ryanodine receptors (RyRs), transforming growth fac-
tor-b receptor complex, and inositol-P3-receptors (Harrar et al.,
2001), but also influences protein kinase signaling. FKBP12
bound to rapamycin regulates the kinase mammalian target of
rapamycin (mTOR, also known as FRAP or RAFT) (Jacinto and
Hall, 2003). The regulation of mTOR and its downstream effec-
tors are highly conserved from yeast to humans (Hay and Sonen-
berg, 2004). The most studied function of mTOR is its role in reg-
ulating protein translation, primarily cap-dependent translation
initiation. mTOR phosphorylates 4E-BP, an inhibitory protein
that acts to sequester the translation initiation factor eIF4E
(Klann and Dever, 2004). Another important target of mTOR is
p70 S6 kinase (S6K), which has been shown to phosphorylate
and activate eIF4B, thereby stimulating the DEAD box helicase
eIF4A to unwind the inhibitory secondary structure in the 50 un-
translated region of eukaryotic mRNAs (Raught et al., 2004).
Thus, activation of mTOR results in the stimulation of translation
initiation via the regulation of both 4E-BP and S6K.
FKBP12 is the intracellular receptor for rapamycin, a com-
monly utilized inhibitor of mTOR signaling. Rapamycin-bound
FKBP12 binds and inhibits mTOR (Brown et al., 1994). mTOR
is also regulated by other associated proteins (Kim et al., 2002;
Loewith et al., 2002; Sarbassov et al., 2004), including the regu-
latory associated protein of mTOR (Raptor); mTOR bound to
Raptor is commonly referred to as mTOR complex 1 (mTORC1).
Raptor enhances the interaction of mTOR with S6K, promoting
cell growth. mTORC1 formation is inhibited by rapamycin, but
the extent of the inhibition is dependent on the nutrient state of
the cell, suggesting the existence of variablemTOR-Raptor inter-
action states (Kim et al., 2002).
New protein synthesis is required for many long-lasting forms
of synaptic plasticity and long-term memory (LTM) (Kelleher
et al., 2004b; Klann and Dever, 2004). Given the central role of
mTOR in translation control, ascertaining its regulation in
neurons is vital to elucidating the regulation of protein synthesis
during synaptic plasticity and memory. We examined the effects832 Neuron 60, 832–845, December 11, 2008 ª2008 Elsevier Inc.
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mTOR Dysregulation Leads to Perseverative Behaviorof the genetic deletion of the FKBP12 protein onmTOR signaling,
synaptic plasticity, and memory. In biochemical experiments
we found that deletion of FKBP12was associatedwith enhanced
mTOR phosphorylation, an increase in the interaction between
mTOR and Raptor, and enhanced phosphorylation of the mTOR
target S6K. In electrophysiological studies we found that the de-
letion of FKBP12 resulted in enhanced late-phase LTP (L-LTP)
that was resistant to rapamycin but blocked by inhibitors of
protein synthesis. Behavioral experiments revealed that the
FKBP12 mutant mice exhibit enhanced contextual fear, repeti-
tive behavior, and perseveration in several assays of memory,
phenotypes that have been observed in several cognitive
disorders, including autism spectrum disorder (ASD), obses-
sive-compulsive disorder (OCD), schizophrenia, and Hunting-
ton’s disease. Taken together, our findings demonstrate that
FKBP12 normally acts to constrain mTOR signaling during
long-term synaptic plasticity, memory, and perseverative be-
haviors.
RESULTS
FKBP12 Is Selectively Disrupted in the Hippocampal
Area CA1
A general deficiency in FKBP12 produces an embryonic lethal
phenotype due to altered cardiac development (Shou et al.,
1998). For this reason, we employed a strategy of selective
FKBP12 ablation using a floxed allele of FKBP12 (Fkbp12fl)
crossed with a brain-specific Cre recombinase mouse line
(T-29). The maximal onset of Cre recombinase expression in
this mouse line is delayed until approximately 3 weeks after birth,
allowing normal development in the presence of FKBP12.
Furthermore, Cre expression is primarily restricted to area CA1
of the hippocampus and the forebrain (Tsien et al., 1996). The
presence of the Fkbp12fl allele or Cre transgene was determined
using PCR-specific primers (Figure 1A).
The absence of FKBP12 in hippocampal area CA1 was con-
firmed by immunoblotting and immunohistochemical staining
(Figures 1B and 1C). To examine the possibility that a closely re-
lated FKBP12 homolog, FKBP12.6, was upregulated by deletion
of FKBP12, we utilized antibodies that detect both proteins
(Figure 1B). Upregulation of FKBP12.6 did not occur in response
to the genetic disruption of FKBP12. Given the recent finding that
FKBP38 can function as a direct inhibitor of mTOR (Bai et al.,
2007), we also examined FKBP38 levels in the brain and found
that FKBP38 is expressed at low levels in the cortex and hippo-
campus (Figure S1D available online). Interestingly, in a survey of
several tissues we found that FKBP12 levels were highest in the
mouse prefrontal cortex and hippocampus, and were expressed
in a pattern inversely correlated with that of FKBP38 (Figures 1E
and S1D). In wild-type mice, FKBP12 protein expression was
detected in the somatic layers in area CA1 of the hippocampus
(Figure 1B) and in area CA3 (data not shown). In FKBP12 condi-
tional knockout (cKO) mice, the staining for FKBP12 was nearly
absent. Higher-resolution examination showed dense staining of
FKBP12 in the soma, with less dense but punctate staining in the
dendritic layer of stratum radiatum (Figures 1CA and 1CB). This
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Figure 1. FKBP12 Is Selectively Deleted
from the Mouse Hippocampus and Fore-
brain
(A) PCR identification of alleles of Fkpb12fl- and
aCaMKII-Cre-driven Cre.
(B) Western blot analysis using antibodies to
FKBP12 showing elimination of FKBP12
hippocampal area CA1.
(C) FKBP12 is primarily localized to cell body layer
in area CA1. (CA) In wild-type mice, FKBP12 is
highly enriched in the cell body layer. (CB) 403
magnification of cell body layer in wild-type mice.
(CC) FKBP12 is largely absent in FKBP12 cKO
mice. (CD) 403magnification of the cell body layer
in FKBP12 cKO mice.
(D) FKBP12 is present in synaptoneurosomes of
wild-type (WT) mice and is reduced in FKBP12
cKO (KO) mice.
(E) aCaMKII-Cre-driven Cre disruption of FKBP12
in other regions of the brain. Expression is quanti-
fied as percentage of wild-type expression for the
tissue and brain region examined. FKBP12 cKO
expression: area CA1, 10%; area CA3/DG, 42%;
cerebellum, 87%; midbrain, 64%; prefrontal
cortex, 22%; amygdale, 21%; diaphragm, 104%;
liver, 99%; heart, 102.3%; 20 mg/ lane. *p < 0.05,
**p < 0.01, ***p < 0.005, ANOVA.
(F) FKBP12 protein levels in KO are expressed at
similar levels to those in WTmice in tissues outside
the nervous system. Quantification included with
Figure 1E, mean ± SEM. Lysates were prepared
from tissues extracted from WT and KO mice;
75 mg/ lane, b-actin controls not shown.Neuron 60, 832–845, December 11, 2008 ª2008 Elsevier Inc. 833
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mTOR Dysregulation Leads to Perseverative Behaviorstaining was largely absent in FKBP12mutant mice (Figures 1CC
and 1CD). Fractionation experiments with hippocampal homog-
enates revealed that FKBP12 is normally present in the synapto-
neurosome fraction and the cellular supernatant (Figure 1D). To
determine whether the transgenic Cre line we used for this study
was expressed in other parts of the brain, we examined FKBP12
levels in other brain regions and tissues. We found nearly normal
levels of FKBP12 in the cerebellum but reduced levels of FKBP12
in the midbrain (Figure 1E). Strikingly, FKBP12 levels were re-
duced to 20% of wild-type levels in the prefrontal cortex and
amygdala, with expression reduced to levels similar to those dis-
played in hippocampal area CA1 of the cKO mice (Figure 1E).
Finally, to confirm that the gene was not disrupted in other tis-
sues, we examined FKBP12 levels in muscles and organs of
the periphery and observed that FKBP12 expression was similar
in mutant andwild-typemice (Figures 1E and 1F). We also exam-
ined basal FKBP12 expression inmice that were homozygous for
the floxed FKPB12 allele but did not express Cre recombinase.
We found that FKBP12 was expressed at similar levels to those
inmice homozygous for thewild-typeFKBP12 allele (FigureS1A).
In addition, FKBP12 protein was removed from area CA1 as early
as P14 (Figure S1B). However, the removal of FKBP12 did not
occur early enough in development or to a degree sufficient to
result in lethality, as expected numbers of cKO pups were
generated (data not shown). In summary, forebrain-specific dis-
ruption of FKBP12 was achieved via bypassing the critical devel-
opmental period for which FKBP12 is required.
mTOR Phosphorylation, mTOR-Raptor
Interactions, and S6K Phosphorylation
Are Enhanced in FKBP12 cKO Mice
FKBP12 serves as an intracellular receptor for rapamycin and
mediates the activity of this immunosuppressant. Rapaymycin
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Figure 2. mTOR Phosphorylation, S6K
Phosphorylation, and mTOR-Raptor Inter-
actions Are Increased in FKBP12 cKO Mice
(A) mTOR phosphorylation is increased in FKBP12
cKO mice. Wild-type (WT), n = 5; FKBP12 cKO
(KO), n = 6; **p < 0.01.
(B) Western blot analyses of downstream mTOR
targets. Proteins examined: p-4EBP, phospho-
4EBP1 (Thr 37/46); 4E-BP; p-S6K1(421),
phospho-S6K1 (Thr 421/424); p-S6K(389), phos-
pho-S6K1 (Ser 389); b-Tub, beta-tubulin;
FKBP12. n = 4, each genotype. WT, n = 5; KO,
n = 6; *p < 0.05.
(C) Raptor binding to mTOR is increased in
FKBP12 cKO mice. IP of protein isolated from
hippocampal lysates with antibodies to mTOR
(IP:mTOR) andRaptor (IP:Raptor). IP:mTOR, n = 5;
IP:Raptor, n = 3. *p < 0.05, Student’s t test.
binds FKBP12 and occupies a conserved
binding domain within mTOR, blocking
its normal signaling (Kim et al., 2002).
Given the unlikely scenario that FKBP12
evolved to bind macrolide toxins, we hy-
pothesized that the loss of FKBP12might
result in enhanced mTOR signaling. To test this hypothesis, we
analyzed the phosphorylation of mTOR at residues correlated
with its activation in the FKBP12-deficient mice. In FKBP12
cKO mice, we observed an increase in the level of mTOR phos-
phorylation at serine-2448 in hippocampal area CA1 homoge-
nates. These findings suggest that FKBP12 suppresses mTOR
signaling even in the absence of rapamycin.
We also examined the phosphorylation of several downstream
targets of mTOR. Although we detected a trend toward in-
creased levels of phosphorylated 4E-BP in the FKBP12 cKO
mice, the differences were not statistically significant (Figure 2B).
Another target of mTOR is S6K. It is phosphorylated at serine-
389 by mTOR and threonine-421 by extracellular signal regu-
lated kinase (ERK) (Zhang et al., 2001). We observed increased
phosphorylation of S6K at threonine-389, but no difference in
phosphorylation at threonine-421/424 (Figure 2B). These results
indicate that although mTOR signaling may be enhanced home-
ostatically in the FKBP12 cKO mice, its downstream targets are
differentially regulated.
The complex formed by FKBP12-rapamycin occupies the
same binding site within mTOR that is required for interaction
with Raptor, a protein that facilitates mTOR signaling. Because
the FKBP12-rapamycin complex displaces Raptor, we hypothe-
sized that a deficiency in FKBP12 would enhance the interaction
between mTOR and Raptor (Kim et al., 2002). To test this possi-
bility, we isolated tissue from area CA1 and immunoprecipitated
mTOR protein complexes using an mTOR antibody. We found
increased levels of mTORC1 in FKBP12 cKO mice when com-
pared with wild-type mice (Figure 2C). These differences were
not due to alterations in total levels of either Raptor or mTOR.
Similar results were obtained when we used a Raptor antibody
for the immunoprecipitation (IP) (Figure 2C). Furthermore, when
Raptor was examined in extracts obtained from the unbound834 Neuron 60, 832–845, December 11, 2008 ª2008 Elsevier Inc.
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from the cKO mice (Figure S1C). These increases were quanti-
fied and correlated with the levels of increased p-mTOR in the
FKBP12 cKO mice. Moreover, because Raptor promotes
mTOR binding to S6K, one would predict that the IPs prepared
from FKBP12 cKO mice would yield increased S6K. Indeed,
we observed an increase in S6K levels in the IPs from the
FKBP12mutant mice (Figure S1C). Together, these data support
the idea that FKBP12 is normally involved in the suppression of
mTOR activity and signaling.
FKBP12 cKO Mice Display Normal Basal Synaptic
Transmission and E-LTP
We next examined synaptic plasticity at the Schaffer collateral-
CA1 synapse in hippocampal slices from the FKBP12 mutant
mice. Because the absence of FKBP12 can increase calcium
leak from the RyR, an intracellular calcium release channel, it
was possible that the loss of FKBP12would affect basal synaptic
function (Berridge, 1998). We found that basal synaptic trans-
mission, measured as synaptic output in response to a stimula-
tory input, was normal in FKBP12 cKOmice (Figure 3A). We next
examined whether FKBP12 was required for paired-pulse facili-
tation (PPF), a form of presynaptic plasticity evoked by two tem-
porally linked stimuli (Katz and Miledi, 1968). PPF was normal in
FKBP12 cKO mice when compared to that in wild-type mice at
several time intervals (Figure 4B). The same measurements of
synaptic function also were examined in FKBP12 heterozygote
(aCaMKII-Cre+/Fkbp12fl/+) mice and were indistinguishable
from those of both wild-type and FKBP12 homozygote cKO
mice (data not shown).
We next examined early-phase LTP (E-LTP) in hippocampal
slices prepared from the FKBP12 cKO mice. E-LTP was elicited
by two different patterns of stimulation: one train of high-
frequency stimulation (HFS) or a single pattern of theta-burst
stimulation (TBS). A single train of either HFS (Figure 3C) or
TBS (Figure 3D) elicited E-LTP in slices from the FKBP12 cKO
mice that was indistinguishable from that of wild-type
littermates. These results suggest that the loss of FKBP12
has no apparent effect on the underlying molecular mechanisms
involved in the establishment of transient (protein-synthesis-
independent) forms of hippocampal LTP.
FKBP12 cKO Mice Have Enhanced L-LTP and L-LTP
Induction Increases mTORC1
To determine whether the removal of FKBP12 altered L-LTP, we
stimulated hippocampal slices with four spaced trains of HFS.
Following this induction protocol, L-LTP in the FKBP12-deficient
mice was significantly enhanced when compared with that of
their wild-type littermates (representative traces are shown in
Figure 4A). Cumulative data from several experiments indicated
that L-LTP in FKBP12 cKO mice was increased for the duration
of the 3 hr experiment compared with L-LTP in control mice
(Figure 4B). Similar results were obtained when L-LTP was eli-
cited by multiple patterns of TBS (Figures 4C and 4D). These re-
sults indicate that the loss of FKBP12 enhances long-lasting
forms of LTP in area CA1 that normally require protein synthesis.
We also examinedwhether the relative levels of mTORC1were
dynamically regulated. To accomplish this, we elicited L-LTP in
hippocampal slices using four trains of HFS, and immunoprecip-
itated mTOR protein complexes. Analysis of IP complexes
isolated 10 min after the final train of HFS revealed a robust in-
crease in the overall level of mTOR-Raptor binding (Figure 4E).
The observed increase in mTORC1 formation was also specific
to the L-LTP stimulation because the observed increase in
mTOR-Raptor association was only observed in area CA1, and
not in other regions of the hippocampus that were not stimulated
(Figure 4F). Interestingly, we found no further increase in
mTORC1 formation in FKBP12 mutant mice 10 min after HFS,
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Figure 3. FKBP12 cKO Mice Have Normal
Basal Synaptic Transmission and Express
Normal E-LTP
(A) Input versus output plot indicating that wild-
type and FKBP12 cKO mice have comparable
fEPSP slopes evoked by increasing stimulation.
Wild-type (WT) mice, FKBP12 cKO mice (KO),
n = 20 slices, 12 mice per genotype. p > 0.05,
Student’s t test.
(B) FKBP12 cKO mice exhibit normal PPF com-
pared to their wild-type littermates. The percent
facilitation, determined by the ratio of the second
fEPSP to the first fEPSP, is shown at interpulse
intervals from 10 to 300 ms. WT, n = 25 slices;
KO, n = 26 slices; 14 mice per genotype.
(C) A single train of HFS evoked similar levels of
E-LTP in wild-type and FKBP12 cKOmice that de-
cayed to baseline after 80 min. WT, n = 12 slices;
KO, n = 13 slices; six to nine mice per genotype.
p > 0.05, ANOVA.
(D) A single pattern of TBS evoked similar levels of
E-LTP in WT and KO mice that decayed to base-
line after 80 min. WT, n = 14 slices; KO, n = 15
slices; seven to ten mice per genotype. p > 0.05,
ANOVA.Neuron 60, 832–845, December 11, 2008 ª2008 Elsevier Inc. 835
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and 4E). However, when we examined mTORC1 levels 60 min
post-HFS stimulation in wild-type slices, we found mTORC1
levels had returned to prestimulation levels, whereas mTORC1
levels in FKBP12 mutant slices remained elevated. Although
not significantly different from unstimulated (no HFS) slices, the
overall levels of mTORC1 in FKBP12 cKO slices at 60 min
post-HFS were significantly higher than those 10 min post-HFS
(Figure 4G), suggesting that newly formed mTORC1 in
FKBP12-deficient mice is resistant to the molecular processes
downregulating this interaction in wild-type mice. These data
indicate that the interaction between Raptor and mTOR is dy-
namically regulated and that the modulation of this interaction
is circuit specific.
Enhanced L-LTP in FKBP12 cKO Mice Is Insensitive
to Rapamycin but Sensitive to Inhibitors of Protein
Synthesis
Rapamycin inhibits L-LTP without affecting the early phase of
synaptic enhancement (Tang et al., 2002), consistent with the
notion that mTOR-dependent regulation of translation initiation
is required for more durable, long-lasting forms of LTP. Because
FKBP12 is the intracellular receptor that binds rapamycin, one
would predict that L-LTP in the FKBP12-deficient slices would
be resistant to rapamycin. Consistent with this prediction,
rapamycin blocked L-LTP evoked by multiple trains of HFS in
wild-type slices, but did not significantly affect L-LTP in slices
from the FKBP12 cKOmice (Figures 6A and 6B). This result sup-
ports a role for FKBP12 as a mediator for rapamycin-dependent
blockade of L-LTP and provides evidence that homologs of
FKBP12, like FKBP12.6, do not play redundant molecular roles
for FKBP12 during L-LTP.
Under normal conditions, L-LTP is critically dependent on the
de novo synthesis of mRNAs and proteins (Frey and Morris,
1997). Overlaying these processes are complex signal transduc-
tion cascades that regulate the synthesis of these new gene
products. Because the loss of FKBP12 has the potential to not
only influence protein synthesis by modulating mTOR signaling,
but also affect calcium signaling via RyRs or phosphatase signal-
ing via calcineurin, we next determined whether the enhanced
L-LTP in FKBP12-deficient mice required protein synthesis. In-
cubation of slices with the protein synthesis inhibitor anisomycin
significantly attenuated L-LTP in both FKBP12 cKO and wild-
type mice (Figures 5C and 5D). This was especially evident at
later time points (t > 160 min), when L-LTP in slices from the
FKBP12 mutant mice was indistinguishable from that in slices
from wild-type mice (Figure 5D). There was a trend for enhanced
potentiation during intermediate time points (t > 60 min and t <
160 min), indicating the possibility that the removal of FKBP12,
in addition to alteringmTOR signaling, might influence other mol-
ecules that contribute to the enhanced L-LTP observed in these
mice. Although anisomycin treatment prevented the L-LTP en-
hancement in FKBP12 cKO slices following four trains of HFS,
a significant enhancement was still observed in the early phase
of potentiation following the induction of TBS-LTP (Figure 4D).
This phase of LTP is resistant to inhibitors of protein synthesis;
thus, we cannot rule out the possibility that in addition to enhanc-
ing protein-synthesis-dependent LTP, FKBP12 removal alters
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Figure 4. FKBP12 cKO Mice Express
Enhanced L-LTP and L-LTP Induction
Stimulates mTOR-Raptor Interactions
(A) Representative traces of fEPSPs in slices from
wild-type (WT) and FKBP12 cKO (KO) mice that
received four trains of HFS.
(B) Four trains of HFS elicited L-LTP in FKBP12
KO mice that was enhanced compared with that
evoked in WT mice. WT, n = 12 slices; KO, n = 14
slices; five to eight mice per genotype. p < 0.05,
ANOVA.
(C) Representative traces of fEPSPs from WT and
KO slices that received three patterns of TBS.
(D) Three patterns of TBS elicited L-LTP in
FKBP12 cKO mice that was greater that that
evoked in wild-type mice 90 min poststimulation.
WT, n = 8 slices; KO, n = 9 slices; four to six mice
per genotype. p < 0.05, ANOVA. For both 43 HFS
and 33 TBS: WT: a, baseline; c, poststimulation;
KO: b, baseline, d, poststimulation.
(E) Raptor binding to mTOR increases following
L-LTP-inducing stimulation. In FKBP12 cKOmice,
Raptor binding to mTOR is near saturation.
(F) Following stimulation of the Schaffer collaterals
to area CA1, increased Raptor binding is
observed in area CA1, but not area CA3.
(G) mTORC1 formation increases 10 min after
HFS stimulation in wild-type slices, but does not
do so in KO slices. mTORC1 levels return to
baseline 60 min post-HFS in wild-type slices but
remain significantly elevated in KO slices compared with 10 min post-HFS, but not basal (unstimulated), slices. Steady-state Raptor association with mTOR
is initially higher in KO slices. No HFS: WT, n = 6; KO, n = 6; HFS + 100: WT, n = 6; KO, n = 6; HFS + 600: WT, n = 5; KO, n = 5. *p < 0.05, **p < 0.01, ANOVA.836 Neuron 60, 832–845, December 11, 2008 ª2008 Elsevier Inc.
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IP3 receptor activity, in the early phase of potentiation following
some patterns of stimulation.
FKBP12 cKO Mice Have Enhanced Associative
Contextual Memory and Altered Object Recognition
Memory
To determine whether the lack of FKBP12 alters associative
learning and memory, we tested the FKBP12 cKO mice with
a conditioned fear paradigm. In this paradigm, mice learn to
fear an environmental context or an emotionally neutral condi-
tioned stimulus (CS, white noise) resulting from its temporal as-
sociation with an aversive unconditioned stimulus (US, foot
shock). When exposed to the same environmental context (con-
textual conditioning) or CS (cued conditioning) at a later time,
conditioned mice demonstrate a stereotypical fear response,
termed freezing (Fanselow, 1984; Phillips and LeDoux, 1992).
For contextual and cued conditioning, FKBP12 cKO mice and
their wild-type littermates were trained with two CS-US pairings.
Both groups of mice displayed similar levels of freezing prior to
training (data not shown) and exhibited comparable short-term
memory (STM) performance following both contextual training
(1 hr after training) and cued training (2 hr after training) (Fig-
ure 6A). When combined, these results suggest that FKBP12-
deficient mice can learn and remember to associate neutral
stimuli with an aversive event when tested following a short delay
interval. Importantly, these data also demonstrate that the
FKBP12-deficient mice display similar levels of stereotypic
freezing behavior relative to wild-type mice. When LTM was ex-
amined 24 hr after training, the FKBP12 cKOmice demonstrated
a significant increase in freezing to the contextual cues associ-
ated with the foot shock. In contrast, both genotypes showed
similar levels of freezing to the auditory cue. These findings
suggest that FKBP12-deficient mice display enhanced contex-
tual memory, but not cued memory, following a 24 hr delay
(Figure 6A). FKBP12 mutant and wild-type mice trained using
a single CS-US pairing displayed low levels of freezing that
were indistinguishable from one another (data not shown).
The initial associative fear memory experiments tested the
same mice for both STM and LTM memory 24–25 hr after
training. One possible explanation for the observed fear memory
enhancement in FKBP12 cKO mice is that they have impaired
extinction; normally, prior contextual exposure diminishes freez-
ing after 24 hr (Lattal and Abel, 2001). To test this possibility,
mice were tested for contextual fear memory 24 hr, but not 1 hr,
after training. Similar to the previous findings, FKBP12-deficient
mice displayed an increase in freezing behavior compared
with wild-type mice following the 24 hr delay interval. Thus, the
memory augmentation observed in FKBP12mutant mice is likely
due to enhancedmemory formation rather than an impairment in
extinction. These results indicate that FKBP12 normally plays
a role regulating the formation of long-term associative contex-
tual fear memory.
We next examined whether contextual conditioning in wild-
type mice increased mTORC1 levels in a manner comparable
to that following L-LTP induction. Mice were trained using the
conditioned fear paradigm and extracts were prepared from hip-
pocampal area CA1. Experimental groups included mice that
had been directly removed from their home cage (naive), mice
that were exposed to the training environment but were not
exposed to the shock (US) or tone (CS) (context), or mice that
received fear conditioning (CS-US) and were allowed to recover
for either 15 or 60min after training (context + shock 150, context +
shock 600). Compared with untrained mice, we detected a signif-
icant increase in mTORC1 formation in mice exposed to the fear
conditioning paradigm 15 min posttraining (Figure 6C). Although
there was a similar trend for context exposure alone, these
results were not significant. FKBP12-deficient mice exhibited
an analogous trend for increased mTORC1 formation in the con-
text alone situation and 15 min after fear conditioning, but these
increases were not statistically significant. Similar results were
detected in area CA3 following fear conditioning (Figure S3D).
The increases in mTORC1 formation following contextual fear
conditioning suggest that mTORC1 signaling is altered by
learning that takes place during exposure of the mice to the
CS-US in the novel training environment.
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Figure 5. Enhanced L-LTP in FKBP12 cKO
Mice Is Resistant to Rapamycin but Sensi-
tive to Anisomycin
(A) Representative fEPSP traces in slice from
wild-type (WT) and FKBP12 cKO (KO) mice that
received four trains of HFS in the presence of
rapamycin or vehicle.
(B) Four trains of HFS in the presence of rapamy-
cin elicited enhanced L-LTP in FKBP12 cKO mice
but blocked L-LTP in wild-type mice. WT+vehicle,
n = 8 slices; KO+vehicle, n = 8 slices; WT+rapa-
mycin, n = 12 slices; KO+rapamycin, n = 19 slices;
five to eight mice per genotype and treatment.
p < 0.05, ANOVA.
(C) Representative fEPSP traces from WT and KO
slices that received four trains of HFS in the
presence of either anisomycin or vehicle.
(D) Four trains of HFS in the presence of anisomy-
cin blocked L-LTP in both FKBP12 KO mice and
WT mice. WT+vehicle, n = 9 slices; KO+vehicle, n = 14 slices; WT+anisomycin, n = 11 slices; KO+anisomycin, n = 11 slices; six to ten mice per genotype.
p < 0.05, ANOVA. For both rapamycin and anisomycin treatments: (WT) a, baseline, c, post stimulation+drug. (KO) b, baseline, d, post stimulation+drug.Neuron 60, 832–845, December 11, 2008 ª2008 Elsevier Inc. 837
Neuron
mTOR Dysregulation Leads to Perseverative BehaviorThe enhanced fear memory displayed by the FKBP12 cKO
mice could be due to subtle differences in expression of other
behaviors such as decreased activity or increased anxiety. Al-
though it is unlikely that the mutant mice have decreased activity
or increased anxiety because the FKBP12-deficient and
wild-type mice displayed similar levels of freezing following the
short-test interval, additional behavioral measures were em-
ployed to more directly assess activity and anxiety-like traits in
an unconditioned paradigm (Bouwknecht and Paylor, 2008). To
determine whether FKBP12-deficient mice displayed a general-
ized decrease in activity and/or increase in anxiety in other
settings, we performed open field analysis (OFA). OFA testing
revealed no significant differences between FKBP12 cKO and
wild-type mice in overall time spent moving, resting, or rising
vertically. Similarly, time spent in the center of the open field or
performing stereotypical movement was also indistinguishable
between genotypes (Figure S2A). Another behavioral task
employed to examine repetitive and stereotypic behavior is the
marble burying task. The marble burying assays the tendency
of mice to dig and bury objects, and alterations in marble burying
reflect changes in this normal perseverative/repetitive behavior.
The results from the marble-burying test revealed that the
FKBP12 cKO mice bury significantly more marbles compared
with their wild-type littermates (Figure 6D), indicating that the
FKBP12 cKO mice display increased perseverative/repetitive
behavior in this setting.
We next examined the FKBP12 cKOmice for novel object rec-
ognition memory. The novel object test can be used to examine
STMand LTM aswell as anxiety inmice (Ennaceur andDelacour,
1988). In this test, the mice were exposed and habituated to two
different but neutrally attractive objects. On the test day, the
mice were exposed to one of the previously presented objects
(the familiar object) and a new object (the novel object). Time
spent exploring both objects was recorded and an index was
generated to measure preference for the novel object. As ex-
pected, wild-type mice preferred the novel object during the
testing period. In contrast, the FKBP12 cKO mice preferred the
familiar object during novel object testing (Figure 6E). The differ-
ence betweenwild-type and FKBP12-defcient mice could not be
accounted for by exploration time or inherent preference value of
the novel object (Figure 6E). There are several explanations for
these findings. First, the data could indicate that the FKBP12
mutant mice display a memory deficit during the execution of
this particular task. However, this is unlikely because if the
FKBP12-deficient mice did not remember the objects then
they would have displayed an equal preference for both the
familiar and novel object, yet they showed a clear preference
for the familiar object. Second, the FKBP12-deficient mice could
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Figure 6. FKBP12 cKO Mice Display En-
hanced Contextual Associative Fear Mem-
ory, Altered Novelty Interaction, and In-
creased Perseverative/Repetitive Behavior
(A) Mean freezing behavior of wild-type (WT) and
FKBP12 cKO (KO) mice. Both genotypes per-
formed similarly during training and had similar
freezing behavior in both STM contextual and
cued memory tests. FKBP12 KO mice display
enhanced freezing during LTM contextual fear
memory testing but no difference in cued associa-
tive fear memory. *p > 0.05, one-way ANOVA.
(B) FKBP12 cKO mice display enhanced contex-
tual LTM in the absence of STM testing. *p% 0.05,
one-way ANOVA.
(C) mTORC1 levels increase in WT mice following
fear conditioning. mTOR immunoprecipitate com-
plexes were isolated from untreated mice (naive),
mice with training environment exposure only
(con), and fear conditioned mice (context+shock,
FC) allowed to recover 15 or 60 min (FC 150 or
FC 600). mTORC1 levels compared with naı¨ve WT
control are shown. Naive levels: KO, 179% ± 21%.
Context: WT, 156% ± 28%; KO, 208% ± 30%. FC
150: WT, 172% ± 23%; KO: 214% ± 31%. FC 600:
WT, 104% ± 9%; KO: 176% ± 18%. *p < 0.05,
**p < 0.01, ANOVA. WT, n = 5; KO, n = 4 for each
time point.
(D) FKBP12 cKO mice display greater repetitive
behavior as determined by marble burying during
30 min test period. Marbles buried: WT: 10.9 ±
1.9; KO: 15.3 ± 0.9. *p < 0.05, ANOVA.
(E) FKBP12 cKO mice display preference for the
familiar object during object recognition analysis.
Dashed line represents PI = 0.5, or neutral prefer-
ence. WT mice, n = 11; KO, n = 10. *p < 0.05,
+p < 0.05, ++p < 0.01, ANOVA.838 Neuron 60, 832–845, December 11, 2008 ª2008 Elsevier Inc.
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mTOR Dysregulation Leads to Perseverative Behaviorhave an increase in anxiety toward the novel object, which we
also believe is unlikely given that they do not display increased
anxiety in other settings. The final possible explanation is that
the FKBP12 mutant mice exhibit a preference for the familiar
object, reflecting either perseveration for the familiar object or
an inability to inhibit responding to the familiar object.
FKBP12 cKO Mice Display Enhanced Perseveration
Following Repeated Acquisition Paradigm Morris Water
Maze Training and the Y-Maze Reversal Task
To test the hypothesis that FKBP12-deficient mice display
increased perseveration, impaired inhibition, or both, we exam-
ined the performance of FKBP12-deficient mice on two water-
escape tests. In the first test, we used the Morris water maze
(MWM) (Morris, 1984). During ‘‘standard’’ hidden-platform train-
ing, the FKBP12 cKO mice and their wild-type counterparts
displayed similar escape latencies to locate the hidden platform
(Figure S3A). During a probe test on day 8, the two groups of
mice both displayed spatially biased search behavior in the train-
ing quadrant relative to the other quadrants (Figure S3B and
S3C), indicating that the wild-type and FKBP12-deficient mice
located the hidden platform using similar spatial search strate-
gies. The two groups of mice also performed similarly on an
earlier probe test, conducted on day 4 of the 8 day training
(Figure S3D). Using a 4 day protocol, performance of the wild-
type and FKBP12 cKO mice was also indistinguishable (data
not shown).
To more specifically determine whether the FKBP12-deficient
mice displayed perseverative behavior in the MWM, we chal-
lenged their ability to learn the location of the hidden platform
when moved to different locations using a modified version of
the delayed match to place MWM paradigm, termed the
repeated acquisition paradigm (RAP; see Experimental Proce-
dures for more detail). This MWM paradigm tests the ability of
the mice to use information gathered during a brief period of
time and forces them to employmore transient forms ofmemory.
FKBP12 cKO mice performed similarly to their wild-type litter-
mates during the reference memory phase of the training
(Figure 7B). The FKBP12 cKO mice displayed notable persever-
ation for the original reference training platform location
(Figure S3E), but their escape latency times were not different
compared to those of wild-type littermates. However, on the
second day of training, when the hidden platform had been
moved to the opposite quadrant of reference memory training,
FKBP12 cKO mice showed reduced latency time compared
with wild-type mice (Figure S3E). This difference was not due
to altered swim speed (data not shown), visual deficiency, or
quadrant preference because escape latency times using
a visible cue (a flag placed on top of the submerged platform)
were identical for both groups (Figure 7A). The enhancement,
although small, became more apparent during later phases of
the RAP paradigm.
Following the reference, reversal, and visible portions of the
RAP paradigm, the submerged platform was moved to random
locations within the water maze. This location was used for only
1 day and was not repeated. The mice were then challenged to
find the new location in four trials, one after the other. Although
the FKBP12-deficient mice appeared to display slightly
faster acquisition of the new platform location on trial-to-trial
comparison, they displayed indistinguishable escape latencies
over the course of the four-trial block (each trial block is con-
tained by a single novel platform location) compared to wild-
type mice (Figure S3F). During the course of the test, both
wild-type and FKBP12 cKO mice displayed a tendency to
search old platform locations while trying to escape the
water maze. An examination of these previous platform cross-
ings (PPCs) revealed that FKBP12 cKO mice showed a signif-
icantly increased number of PPCs when compared with their
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Figure 7. FKBP12 cKO Mice Have Normal
Spatial Learning, Reference Memory, and
Working Memory Following RAP MWM and
Y-Maze Reversal Training but Enhanced
Perseveration for Former Escape Location
and Initial Y-Maze Escape Arm
(A) Escape latency times during initial 9 days of
RAP training.
(B) Previous testing day platform crossings (*p <
0.05). For RAP MWM: WT, n = 11; KO, n = 9;
*p < 0.05, ANOVA. The mean time spent in each
maze quadrant during the probe test is shown.
(C) Percent correct arm choice by trial block num-
ber during training, testing, and reversal phases of
Y-maze experiment. FKBP12 KO mice persever-
ate more for the original training arm than
their wild-type littermates. *p < 0.05, **p < 0.01,
ANOVA.
(D) The number of correct arm choices during
training phase (20 trials) of Y-maze reversal task;
WT = 17.3 ± 0.5, KO = 17.6 ± 0.5. The number of
trials needed to reach criterion (9/10 correct)
during reversal phase of Y-maze reversal task
(WT = 18.5 ± 1, KO = 23.3 ± 1.4) is also shown.
For Y-Maze: WT, n = 13; KO, n = 12. *p < 0.05,
ANOVA.Neuron 60, 832–845, December 11, 2008 ª2008 Elsevier Inc. 839
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mTOR Dysregulation Leads to Perseverative Behaviorwild-type littermates (Figure 7B). Together these results sug-
gest that FKBP12 is involved in inhibiting the tendency to
perseverate and inhibit responding to previously reinforced
locations.
To further challenge this increased perseveration/decreased
inhibition hypothesis in FKBP12 cKO mice, we used a water-
based Y-maze assay. In brief, mice were trained to locate an es-
cape platform located in one arm of a Y-shaped maze. Upon
successful acquisition of the task, mice were given a reversal
test where the position of the escape platform was reversed to
the alternate arm and the ability to learn the new location was
measured. The number of trials to criterion (9/10 correct) on
the reversal test was determined. During training, FKBP12-
deficient mice and their wild-type littermates acquired the initial
escape arm with equal efficacy (Figure 7C), indicating that
FKBP12 is not involved in this form of simple position learning.
However, when the escape arm was reversed, the FKBP12
cKO mice required 25% more trials to achieve the same
escape success criteria compared with wild-type littermates
(Figure 7D). These findings further demonstrate that FKBP12-
deficient mice have impaired performance in learning and
memory assays that require an inhibition of previously reinforced
responses. Performance in this assay is governed predominantly
by cortical-striatal function. Although not reduced to the same
levels as those found in hippocampal area CA1, FKBP12 levels
were significantly decreased in the midbrain of the FKBP12
cKO mice (Figure 1E), which may be sufficient to explain these
results. These results combined with the RAP MWM results
and novel object recognition data suggest that FKBP12 mice
display increased perseverative behaviors.
DISCUSSION
FKBP12 is a modulator of signaling pathways known to be in-
volved in synaptic plasticity, behavioral plasticity, and memory
formation. Thus, it is important to define the mechanism for the
FKBP12-dependent modulation of these processes. Previous
studies had shown that the complete depletion of FKBP12
resulted in near total lethality, precluding studies aimed at the
examination of its role in the cellular and molecular processes
underlying learning and memory. We have taken advantage of
theCre-lox expression system to achieve both spatially and tem-
porally restricted deletion of the FKBP12 gene to circumvent this
problem. We found that deletion of the FKBP12 gene resulted in
biochemical alterations in the mTOR signaling pathway; en-
hanced L-LTP; increased memory following associative fear
conditioning; and enhanced memory perseveration in the novel
object recognition task, RAP version of the MWM, and Y-maze
reversal task. In addition, FKBP12-deficient mice displayed an
increase in perseverative/repetitive behavior in the marble
burying assay. Our studies demonstrate a critical role for an im-
munophilin in learning, memory, and perseverative behaviors,
and define a role for FKBP12 in the regulation of mTOR in the
absence of macrolide toxins. Moreover, these studies may offer
insight into the molecular underpinnings of repetitive behaviors
and perseveration phenotypes presented in ASD, OCD, schizo-
phrenia, and neurodegenerative disorders.
FKBP12 Regulates mTOR-Raptor Interactions
It is unlikely that FKBP12 evolved to normally interact with mac-
rolide immunosuppressants. Clues to its normal cellular function
can, however, be gleaned from the observation that rapamycin
blocks mTOR signaling. Moreover, this interaction disrupts the
interaction between mTOR and Raptor at the FKBP12-binding
domain (FRB) on mTOR (Cafferkey et al., 1993). Not only
does Raptor play a positive role in mTOR signaling, but it also in-
teracts with mTOR at the FRB site. Thus, it is possible that
FKBP12 normally functions to repress mTOR activity by acting
as the intracellular adaptor/receptor for an as yet unidentified
endogenous inhibitor of neuronal mTOR activity, perhaps via
modulation of mTOR-Raptor binding. This idea is further sup-
ported by recent findings establishing direct inhibition of mTOR
in the absence of rapamycin. FKBP38, an FKBP family member
formed from an FKBP-C domain (essentially a minimal consen-
sus FKBP12 sequence) and a pair of protein-protein interaction
domains, was shown to bind Rheb, a potent activator of
mTOR (Bai et al., 2007). This same study showed that HEK293
cells overexpressing FKBP38 displayed decreased mTOR ac-
tivity and conversely, cells in which the levels of FKBP38 had
been decreased with siRNA showed enhanced mTOR signal-
ing. Deletion analysis of FKBP38 showed that its FKBP-C
domain, a region highly homologous to FKBP12, was sufficient
for mTOR binding (Bai et al., 2007). However, FKBP38 is ex-
pressed at very low levels in the brain and is not upregulated
in response to FKBP12 removal (Figure S1D), diminishing the
likelihood that FKBP38 is the major FKBP regulating neuronal
mTOR activity. Instead, we hypothesize that FKBP12 serves
as the critical FKBP suppressor of neuronal mTOR signaling
activity.
The idea that FKBP12 suppresses mTOR signaling is sup-
ported by several lines of experimental evidence presented
herein. First, enhanced phosphorylation of serine-2448 on
mTOR was observed in FKBP12-deficient mice. Although not
a direct assay of mTOR activity, phosphorylation at this site pre-
viously was shown to increase following stimulation of mTOR
signaling with insulin, interleukin-3, or Akt activation (Reynolds
et al., 2002; Scott et al., 1998). Second, in FKBP12 cKO mice,
we observed an increase in the amount of Raptor associated
with mTOR (Figure 2C). This finding is more important when ex-
amined in the context of hippocampal synaptic plasticity and
memory, where L-LTP-inducing stimuli and fear conditioning in
wild-type mice produce a similar increase in mTORC1 formation
(Figures 4E, 4G, and 6C). Finally, we observed enhanced phos-
phorylation of S6K, a translational regulatory kinase and down-
stream target of mTORC1. Taken together, these data strongly
suggest that FKBP12, even in the absence of rapamycin, nor-
mally acts to suppress mTORC1 signaling. Interestingly, not all
downstream targets of mTORC1 were affected by removal of
FKBP12. Notably, basal 4E-BP phosphorylation was unaffected.
This result is consistent with the idea that when FKBP12 is ab-
lated, mTORC1 signaling is sensitized and/or partially activated,
but remains under the control of other regulatory elements. Mul-
tiple signaling pathways converge on mTOR to promote its full
activation in response to a stimulus (Kelleher et al., 2004a). In
this way, mTOR signaling required for long-lasting synaptic
change may be a node at which signal coincidence detection840 Neuron 60, 832–845, December 11, 2008 ª2008 Elsevier Inc.
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mTOR Dysregulation Leads to Perseverative Behaviortakes place, similar to activation of the NMDA receptor and ERK
(Sweatt, 2001; Wittenberg and Tsien, 2002).
FKBP12 could regulate mTOR function in at least two ways.
One obvious mechanism is via its prolyl-isomerase activity.
FKBP12 may simply modulate protein folding associated with
the interaction states that regulate mTOR activity. In addition
to Raptor, mTOR is found to complex with at least four different
proteins (Bai et al., 2007; Hay and Sonenberg, 2004; Vander
Haar et al., 2007). One of these proteins may act as a state con-
ditional repressor of mTOR activity. Intriguingly, although Raptor
has been shown to positively affect mTOR signaling in genetic
and RNAi studies, it has also been shown to negatively affect
mTOR activity in vitro (Kim et al., 2002). It may be that FKBP12
is involved in transitional modification of Raptor between activa-
tion (stimulated) and inhibitory (basal) states (Figure 8A). A sec-
ond possibility is that FKBP12 might act as an intracellular medi-
ator for an unidentified endogenous inhibitor or inhibitors of
mTOR or FKBP12 may be a direct inhibitor of mTOR activity by
precluding Raptor binding (Figure 8B). Signaling involved in trig-
gering protein synthesis could displace FKBP12 through interac-
tion with an unknown adaptor; recent studies suggest Rheb as
attractive candidate for this function (Bai et al., 2007)
(Figure 8B). A possible explanation for the finding that some,
but not all, mTOR substrates are upregulated in FKBP12 mutant
mice is that FKBP12 regulates only Raptor-mediated mTOR sig-
naling. Other substrates such as 4E-BP may be under the regu-
lation of another mTORC1 scaffolding protein such as proline-
rich Akt/PKB substrate-40 (PRAS-40) (Vander Haar et al.,
2007). Interactions between mTOR, FKBP12, and endogenous
inhibitors may be either intrinsically weak or dependent on mul-
tiple proteins in the complex, which may explain why traditional
IP experiments have failed to identify them. Indeed, two mTOR
interactors were identified only in experiments that pulled
down mTOR-binding proteins under crosslinking or less disrup-
tive detergent conditions (Kim et al., 2002; Sarbassov et al.,
2004). In either scenario, immunosuppressants would act as
a conformational mimetics of a normal cellular inhibitor or inhib-
itors that stabilize FKBP12 interaction with mTOR, blocking Rap-
tor access to the FRB domain.
FKBP12 Represses Protein-Synthesis-Dependent LTP
Paralleling the enhancedmemory in the FKBP12 cKOmice is the
finding of enhanced L-LTP. The L-LTP enhancement in the
FKBP12 cKO mice was insensitive to rapamycin, but sensitive
to a general protein synthesis inhibitor (Figure 5D). Although
FKBP12 could also affect calcineurin and RyR signaling, previ-
ous studies argue against these pathways as being responsible
for the observed enhancement of LTP. Enhanced calcineurin
activity would be predicted by the removal of FKBP12; however,
enhanced calcineurin should result in reduced L-LTP and de-
creased learning and memory performance (Hoeffer et al.,
2007; Malleret et al., 2001; Winder et al., 1998). Similarly,
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Figure 8. Models for FKBP12 Modulation of
mTOR-Raptor Interactions to Promote
mTOR Signaling
(A) One of the knownmTOR-binding proteins (Rap-
tor is used for this example) exists in two states
mediated by FKBP12 binding and/or FKBP12
isomerase activity. One state, Raptor-i, represses
mTOR signaling; the other state, Raptor-a, pro-
motes mTOR signaling. Following upstream acti-
vation, Raptor-i is shifted to Raptor-a, which has
greater affinity for mTOR, and mTOR signaling is
promoted.
(B) FKBP12 serves as the intracellular scaffold for
an mTOR inhibitory factor or factors or directly
competeswith Raptor for themTOR FRB site. In ei-
ther scenario, FKBP12 represses mTOR activity by
blocking Raptor interaction with mTOR. In the
FKBP12 cKO mouse, Raptor interaction with
mTOR is increased. Increased mTORC1 levels
result in enhanced S6K, but not 4E-BP, phosphor-
ylation, preventing translational initiation. Protein-
synthesis-inducing stimulation (i.e., L-LTP) either
(1) signals the displacement of inhibitory factor or
factors interacting with FKBP12 or (2) sequesters
FKBP12 from mTOR, allowing Raptor access to
the FRB. Protein-synthesis-inducing signaling in
either wild-type or FKBP12 mutant neurons
promotes mTOR access to 4E-BP, possibly
through activation of additional mTORC1-associ-
ated scaffolds (i.e., PRAS40), allowing translational
initiation. Rheb, Ras-homolog enriched in the
brain; PRAS40, proline-rich Akt/PKB substrate-40
kd; FRB, FKBP12-binding domain; KIN, mTOR
kinase catalytic domain; NRD, domain site of ser-
ine-2448 phosphorylation.Neuron 60, 832–845, December 11, 2008 ª2008 Elsevier Inc. 841
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mTOR Dysregulation Leads to Perseverative Behaviorenhanced RyR function resulting from FKBP12 removal is an
unlikely source for the phenotypes we observe (Van Acker
et al., 2004). Deletion of RyR3, the predominant RyR expressed
in the hippocampus, results in enhanced performance in the
MWMand enhanced E-LTP (Futatsugi et al., 1999). Several stud-
ies have reported genetic deletions that resulted in the transfor-
mation of E-LTP to L-LTP (Banko et al., 2005; Costa-Mattioli
et al., 2005; Malleret et al., 2001; Thomas et al., 1996), but only
rarely have enhancements of L-LTP been observed (Barco
et al., 2003; Wang et al., 2004).
Several features of the observed L-LTP enhancement are
particularly intriguing. First, basal synaptic transmission is ex-
pressed normally in FKBP12-deficient mice. This is important
because FKBP12 has the potential to affect RyR and CaN activ-
ity, both of which influence synaptic function (Futatsugi et al.,
1999; Nishiyama et al., 2000; Winder et al., 1998). Unlike previ-
ous studies reporting shifts to L-LTP following stimulation that
normally produces E-LTP (a single train of HFS), E-LTP in the
FKBP12 cKO mice was normal. This suggests that FKBP12
does not strongly influence the molecular mechanisms regulat-
ing transient change in synaptic strength, but instead plays
a specific role in processes that control persistent changes in
synaptic function. This idea is further supported by the observa-
tion that the L-LTP enhancement in the FKBP12 mutant mice is
sensitive to protein synthesis blockade (Figure 5D). This is impor-
tant for two reasons: it implicates mTOR signaling, which is
critical for translational initiation, and it eliminates the possibility
that the enhanced L-LTP is solely a product of prolonged short-
term signaling (i.e., enhanced calcium release from intracellular
stores).
A parallel can be drawn between the L-LTP and behavioral
phenotypes in the FKBP12 cKOmice. In both short-term plastic-
ity and STM, i.e., those forms of memory involving transient
molecular processes, enhancements were not observed in the
FKBP12 cKO mice. Enhancements were observed in the
FKBP12 cKO mice only in situations where signaling that regu-
lates long-lasting neuronal changes took place. Although
a causal relationship between enhanced L-LTP and enhanced
memory perseveration has not been shown previously, we
propose that this is a potential cellular mechanism for the LTM
enhancements in FKBP12 mutant mice.
The Loss of FKBP12Enhances Perseverative/Repetitive
Behaviors
Our behavioral studies revealed augmented memory and
perseveration in the FKBP12 mutant mice. First, FKBP12 cKO
mice demonstrated enhanced associative contextual fear
memory (Figure 6A). Second, FKBP12-deficient mice displayed
significantly altered performance in the novel object recognition
test, interacting more with the familiar object than the novel
object (Figure 6E). Third, FKBP12 mutant mice demonstrated in-
creased perseveration for previous platform locations during the
RAP MWM and Y-maze assays (Figure 7B). Finally, the FKBP12
cKO mice displayed increased repetitive behavior in the marble
burying task (Figure 6D). These behavioral phenotypes suggest
that FKBP12 regulates neuronal signaling that controls the man-
ifestation of traits that are reminiscent of several neurological
disorders including ASD, OCD, and schizophrenia.
The performance of the mutant mice in the novel object recog-
nition test is interesting because FKBP12 cKO mice displayed
a preference for the familiar object compared with the novel ob-
ject (Figure 6E). Although there are several explanations for these
results (see RESULTS), we believe themost parsimonious expla-
nation and one that is consistent with our other findings is that
FKBP12 is important for behavioral inhibition, and in its absence
mice have increased perseveration. In fact, results from the
MWM and Y-maze tests clearly indicate that FKBP12 cKO
mice have more difficulty inhibiting previously reinforced re-
sponses relative to wild-type littermates. The object recognition,
MWM, and Y-maze tests are all learning- and memory-based
assays, suggesting that FKBP12 may play a significant role in
perseveration/inhibition related to cognition and memory. The
enhanced contextual fear conditioning is also interesting to con-
sider in this context. Unlike contextual LTM in wild-type mice,
contextual LTM was equally enhanced in FKBP12 cKO mice
regardless of the previous exposure during STM testing. This
result, combined with the finding that STM was normally ex-
pressed in FKBP12-deficient mice, indicates that FKBP12 may
play a role in signaling that supports long-term, but not transient,
information storage. The memory enhancements observed in
FKBP12 cKO mice may be due to a shift in the molecular signal-
ing mechanisms regulating balance of memory formation and
removal, shifting the overall process to favor a type of memory
perseveration. However, the marble burying data suggest that
the increase in perseveration may also generalize to domains
of CNS function beyond cognitive domains. Collectively, these
results suggest that FKBP12 regulates the ability of the mouse
to inhibit particular responses, thereby leading to increased per-
severation when eliminated.
Perseveration is a feature of a number of neurodegenerative ill-
nesses, such as AD and Parkinson’s disease (PD) (Griffin et al.,
2005; Joseph, 1999), and is a symptom of conditions derived
from organic sources of neurological disorder such as ASD
and OCD. Our data highlight the increasingly important role of
mTOR signaling in the expression of several neurological dis-
eases. The dysregulation of mTOR signaling has been directly
implicated in the expression of a cellular marker of neuronal
loss in a mouse model of PD (Malagelada et al., 2006). Studies
of mice with a restricted disruption of phosphatase and tensin
homolog (PTEN), a tumor suppressor gene involved in upstream
regulation of mTOR signaling, displayed behaviors consistent
with ASD (Kwon et al., 2006). Protein synthesis is upregulated
in mouse and Drosophila models of fragile X syndrome (FXS)
(Bolduc et al., 2008; Dolen et al., 2007; Hou et al., 2006). These
findings suggest that mTOR signaling may also be enhanced in
FXS, a mental retardation syndrome which has symptoms that
include severe perseverative behavior and is the best-character-
ized genetic cause of autism (DiCicco-Bloom et al., 2006). Our
findings suggest that dysfunction in the regulation of mTORC1
by FKBP12 results in increased perseverative/repetitive behav-
iors such as those observed in ASD. To further explore the role
of FKBP12 in ASD-like traits, it will be important to evaluate
whether the FKBP12-deficient mice have altered social behavior
(e.g., social interactions, sociability, and recognition) and/or
altered communication (e.g., ultrasonic vocalization), two addi-
tional hallmarks of ASD.842 Neuron 60, 832–845, December 11, 2008 ª2008 Elsevier Inc.
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mTOR Dysregulation Leads to Perseverative BehaviorDefining the role of FKBP12 in the brain represents an oppor-
tunity to improve our overall understanding of mTOR signaling
and its relationship to long-term plasticity, behavioral persever-
ation, and memory. The mTOR signaling cascade represents
a critical intersection for the convergence of multiple upstream
neuronal signaling pathways and an equally divergent number
of downstream effectors that are involved in learning and
memory. Given that FKBP12 is a modulator, but not a required
component, of mTOR signaling, it may be an ideal target for ther-
apeutic drug development aimed at ameliorating some of the
mTOR-related pathologies of neurological disease. Persevera-
tive behaviors associated with ASD, OCD, and other related
neurological disorders arewidely believed to be developmentally
established, fixed in utero by genetic, hormonal, and environ-
mental factors (Moldin et al., 2006). Because our studies indicate
that postnatal dysregulation of mTOR signaling can result in
perseverative/repetitive phenotypes, they challenge the idea
that some aspects of these conditions are developmentally
predetermined (Zoghbi, 2003).
EXPERIMENTAL PROCEDURES
FKBP12 cKO Mice
Mice with floxed FKBP12 (Fkbp12fl) alleles were generated as described
previously (Tang et al., 2004). Mice expressing the cre recombinase
Tg(aCaMKII-Cre) (T-29-1), referred to as aCaMKII-Cre, were kindly provided
by Dr. S. Tonegawa. Mice were genotyped using Cre-specific primers and
primers that identify floxed alleles of the FKBP12 locus. The wild-type mice
used in this study were aCaMKII-Cre+/Fkbp12+/+ and cKO mice used in this
study were aCaMKII-Cre+/Fkbp12fl/fl.
Immunoblotting
Soluble protein extracts were prepared by homogenizing the tissue samples in
ice-cold buffer. Synaptoneurosome preparations were completed as
described previously (Villasana et al., 2006). Proteins were resolved on SDS-
polyacrylamide gels using standard techniques. See Supplemental Experi-
mental Procedures for details of buffer and antibody preparations.
Immunoprecipitation
Transverse hippocampal slices (400 mm) were prepared using conventional
techniques. Slices were maintained at 30C in an interface chamber perfused
with oxygenated artificial cerebrospinal fluid (ACSF). See Supplemental
Experimental Procedures for more detail. Efficiency of the IP was determined
by examining the supernatant and wash fractions obtained from the procedure
(Figure S1C).
Electrophysiology
Field EPSPs were recorded from slices prepared in a fashion identical to that
used for IP. Slices were incubated in an interface chamber as described pre-
viously (Banko et al., 2005) and in the Supplemental Experimental Procedures.
When indicated, ASCF was incubated with 20 nM rapamycin (Cell signaling
Technology, Beverly, MA) or 40 mManisomycin (Sigma-Aldrich, St. Louis, MO).
Associative Conditioned Fear
The training sessions for contextual and cued fear conditioning consisted of
a 150 s exploration period followed by two CS-US pairings separated by 1
min (foot shock intensity 0.9 mA, 2 s duration; tone 85 db white noise, 30 s
duration). Contextual memory tests were performed in the training chamber
after 1 hr and 24 hr. Cued memory tests were performed in an environmentally
altered testing chamber either 2 hr or 24 hr following training. Baseline freezing
was monitored (3 min) prior to presentation of the tone (85 db white noise,
3 min duration).
Marble Burying
Mice were placed individually in Plexiglas cages containing fresh 5 cm deep
bedding and 20 small black marbles arranged in five evenly spaced rows of
4 marbles each. Testing was conducted for 30 min under normal room lighting
and white noise conditions. After the test period, mice were removed and the
unburied marbles were counted. Marbles were considered buried if they were
at least one-half covered with bedding.
Novel Object Recognition
Each genotype was pretested for preference to the objects used during the
familiar and novel phases of the experiment. The amount of time spent explor-
ing the novel object was divided by the amount of time exploring both the novel
and familiar objects as determined using a video tracking system. The resulting
value was divided by total time to generate a preference index (PI). See
Supplemental Experimental Procedures for more detail.
MWM and RAP
MWM experiments were performed as previously described (Banko et al.,
2005). The RAP protocol was adapted from previous studies (Gimenez-Llort
et al., 2005). The trajectories of the mice were recorded with a video tracking
system (HVS Image Analyzing VP-200). See Supplemental Experimental
Procedures for more detail.
Arm Reversal in Y-Maze
Mice were trained to locate a submerged escape platform in one arm of a
Y-shaped maze for 20 trials. Once mice achieved a 90% success criterion,
the escape arm was switched and the mice were tested to determine the
latency to find the new escape location. See Supplemental Experimental
Procedures for more detail.
SUPPLEMENTAL DATA
The supplemental data for this article include three Supplemental Figures and
Experimental Procedures and can be found at http://www.neuron.org/
supplemental/S0896-6273(08)00840-4.
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